JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 10, 2003; DOI: 10.1124/jpet.103.059089


0022-3565/04/3082-651-657$20.00
JPET 308:651-657, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.059089v1
308/2/651    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, Y.
Right arrow Articles by Kume, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, Y.
Right arrow Articles by Kume, H.

TOXICOLOGY

Effects of Fluoranthene, a Polycyclic Aromatic Hydrocarbon, on cAMP-Dependent Anion Secretion in Human Airway Epithelia

Yasushi Ito, Masami Son, Shinji Sato, Takamasa Ohashi, Masashi Kondo, Kaoru Shimokata, and Hiroaki Kume

Division of Respiratory Diseases, Department of Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan

Received August 24, 2003; accepted November 4, 2003.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The human respiratory tract is constantly exposed to polycyclic aromatic hydrocarbons (PAHs) through inhalation of atmospheric pollutants. We examined the effects of three PAHs (benzo[a]pyrene, anthracene, and fluoranthene) on the airway ion transport, which is essential for lung defense and normal airway function, using human airway epithelia (Calu-3). These three PAHs had no significant effect on the basal short-circuit current (Isc). However, fluoranthene (1–100 µM) applied in the apical compartment potentiated Isc in response to cAMP-related agents (isoproterenol, forskolin, and 8-bromo-cAMP). The effects of fluoranthene were unaffected by ellipticine, a PAH receptor antagonist. Estimation of the anionic composition of Isc revealed that isoproterenol increased both and Cl transport in the control, whereas it potentiated only Cl transport in the presence of fluoranthene. The fluoranthene-induced modulations of these anion transporters were counteracted by charybdotoxin (ChTx, a hIK-1 channel blocker). Fluoranthene gradually augmented the ChTx-sensitive K+ current (IK) across the basolateral membrane, accompanied by a sustained increase in the cytosolic Ca2+ concentration ([Ca2+]i). In the presence of fluoranthene, however, a much larger hIK-1-dependent IK was identified by the application of 8-bromo-cAMP without concomitant elevation of [Ca2+]i. These results suggest that fluoranthene switches from cAMP-dependent secretion to Cl secretion through the hIK-1 channel, whose sensitivity to protein kinase A may be up-regulated by the sustained [Ca2+]i elevation produced by this chemical.


The human respiratory tract is constantly exposed to noxious materials, including atmospheric pollutants and microorganisms. Among the atmospheric pollutants, polycyclic aromatic hydrocarbons (PAHs) are ubiquitous (Kendall et al., 2002Go). Although cigarette smoke is one of the major sources of PAHs (Hoffmann and Hoffmann, 1997Go), human exposure to these chemicals also occurs from nontobacco sources (Waldman et al., 1991Go). The air in urban areas contains high percentages of PAHs. In lung biopsies, the pulmonary PAH levels of urban residents were higher than those of the rural residents, and the PAH levels increased with age (Lodovici et al., 1998Go). Another major source of PAHs in the air is diesel-exhaust particles (DEP) emitted by motor vehicles (Fromme et al., 1998Go). The PAHs absorbed in the fine particles (1 µm) of DEP remain in the body for quite a long time (Sun et al., 1984Go; Lee et al., 1987Go). Epidemiologically, it has been shown that cigarette smoke and DEP are well associated with various health hazards, including airway infections, bronchial asthma, and chronic bronchitis (Sydbom et al., 2001Go). Recent investigations have revealed that DEP containing PAHs can cause asthma-like conditions, such as airway inflammation, enhanced IgE production, proliferation of goblet cells, increased mucus secretion, and bronchoconstriction (Sagai et al., 1996Go; Diaz-Sanchez et al., 2000Go). Notwithstanding, little has been documented regarding the effects of PAHs on the airway ion transport system, which is required for efficient mucociliary clearance, a primary host defense mechanism (Shimura, 2000Go).

The ion transport system is implicated in mucociliary clearance by producing a thin layer of aqueous fluid called the airway surface liquid (Jayaraman et al., 2001Go). Since the volume of bronchial gland cells exceeds that of surface epithelial cells by a ratio of 30:1 in the human airway, the volume and composition of airway surface liquid are mainly regulated by submucosal gland cells (Shimura, 2000Go). Thus, in the present study, we used Calu-3 human airway cells, which are functionally and morphologically analogous to human airway serous cells, expressing abundant cystic fibrosis transmembrane conductance regulators (CFTR) (Haws et al., 1994Go). This cell line produces and Cl secretion in response to various stimuli like primary submucosal gland cells do (Devor et al., 1999Go).

The present study focused especially on one of the PAHs, fluoranthene, whose toxicological effects have been less studied to date in spite of its environmental ubiquity and high bioactivity (Yamaguchi et al., 1996Go). A recent investigation has found that this chemical is the most abundant PAH in human lung samples: 0.151 ng/g of wet tissue (Goldman et al., 2001Go).


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Cell Culture. The Calu-3 cells (American Type Culture Collection, Rockville, MD) were grown in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium (Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (Invitrogen), 100 µg/ml streptomycin, and 100 U/ml penicillin (Invitrogen) in culture flasks (T75) at 37°C in a humidified atmosphere containing 5% CO2. When 80 to 90% confluent, cells were detached with a solution of phosphate-buffered saline, 0.04% EDTA, and 0.25% trypsin. The collected cells were passaged with a 1:4 dilution of the same solution and seeded onto porous polyester membranes [0.4-µm pore size on Snapwell or Transwell inserts (1.1 cm2; Costar, Cambridge, MA)] at a density of 106 cells/well. The inserts had been collagen-coated overnight with 0.2% human placental collagen type VI (Sigma-Aldrich, St. Louis, MO). On day 1, the medium remaining on the apical side was removed to establish an air interface, which markedly improves the differentiation of human airway epithelia in a well polarized fashion. The cells were fed by replacement of the basolateral medium every 48 h. Experiments were performed after 7 to 13 days in culture.

Solutions. The physiological saline solution (PSS) used in the present study was composed of 115 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose, 10 mM Hepes, and 25 mM NaHCO3. The pH of the solution was adjusted to 7.4 (at 37°C) by NaOH before addition of NaHCO3. The pH of the solution was kept at pH 7.4 when gassed with a mixture of 95% O2/5% CO2. buffers consisted of 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose, and 10 mM Hepes (pH adjusted to 7.4 at 37°C). This solution was circulated with air. For Cl-free buffers, Cl in the PSS was replaced by gluconate. In this solution, Ca2+ was increased to 4 mM to compensate for the Ca2+-chelating capacity of the gluconate. This solution was bubbled with 5% CO2/95% O2.

Bioelectric Studies. When cells had grown confluent, the Snapwell inserts were rinsed with PSS and mounted in modified Ussing chambers (EasyMount Chamber; Physiologic Instruments, San Diego, CA) connected to a VCC MC2 voltage-clamp apparatus (Physiologic Instruments). The monolayers were continuously open-circuited to monitor transepithelial potential differences (PD), and every 20 s, a bidirectional 2-µA pulse was imposed across the epithelium for 0.5 s to cause voltage deflections ({Delta} PD). This procedure enabled us to calculate transepithelial conductance (Gt) by Ohm's law (Gt = 2 µA/{Delta} PD). The short-circuit current (Isc) was recorded by clamping PD to 0 mV by VCC MC2. Isc represents the net flow of negative charges, which is mostly composed of anion current from the basolateral to the apical compartment. To pharmacologically distinguish between - and Cl-dependent transport, the Isc reduction was measured for 10 min after basolateral application of the cotransport inhibitor 4,4'-dinitrostilbene-2,2'-disulfonic acid (DNDS; 3 mM) and the Na+-K+-2Cl cotransport inhibitor bumetanide (50 µM), called DNDS- and bumetanide-sensitive Isc, respectively.

Measurement of Basolateral K+ Current. The K+ current across the basolateral membrane (IK) was estimated after permeabilization of the apical membrane with nystatin (50 µM) for more than 30 to 40 min and establishment of an apical-to-basolateral K+ concentration gradient (Devor et al., 1999Go; Ito et al., 2002aGo,bGo). Apical NaCl was replaced by equimolar K-gluconate, whereas basolateral NaCl was substituted with equimolar Na-gluconate. Cl was removed from these solutions. Previous investigations have demonstrated that major K+ conductance on the basolateral membrane is produced by the human intermediate conductance (10–31 pS) Ca2+-activated K+ (hIK-1) channel (Devor et al., 1999Go; Gerlach et al., 2000Go). To assess the hIK-1 channel-dependent K+ current, we measured IK reduction for 10 min after basolateral application of charybdotoxin (ChTx; 100 nM); this is called the ChTx-sensitive IK.

Measurement of Intracellular Ca2+ Concentration. For intracellular Ca2+ imaging, Calu-3 cells were subcultured on the porous membranes of Transwell inserts (Costar) in 12-well plates. We grew airway epithelial cells as a polarized monolayer on transparent permeable membrane supports to measure [Ca2+]i in response to extracellular PAHs. This culture strategy yields an airway epithelial morphology that closely mimics that in vivo. Before experiments, the apical and basolateral aspects of the confluent monolayer were rinsed twice with PSS and incubated for 1.5 h at 37°C in the same buffer containing 5 µM 1-[2-amino-5-(2,7-dichloro-6-hydroxy-3-oxy-9-xanthenyl)phenoxy]-2-(2'-amino-5'-methylphenoxy)ethane-N,N,N',N'-tetraacetic acid, pentaacetoxymethyl ester (Dojindo Laboratories, Kumamoto, Japan) and 0.01% pluronic F127 (Molecular Probes, Eugene, OR). After the fluorescence loading, cell monolayers were rinsed twice with PSS to wash off residual dyes outside the cells, and thereafter, 0.5 and 1 ml of PSS were added to the apical and basolateral membranes, respectively. Fluorescence signals were collected for 20 ms at 6-s intervals using a fluorometer (Fluoroskan Ascent CF; Labsystem, Helsinki, Finland) at the excitation wavelength of 485 nm and the emission wavelength of 538 nm. The maximum signal (Fmax) was obtained by adding 10 µM ionomycin, and the minimum signal (Fmin) was obtained by adding 10 mM EGTA to the cell monolayer. The [Ca2+]i was calculated according to the following formula:

in which Kd was assumed to be 390 nM. To estimate significant [Ca2+]i changes, average values before and after additions of reagents during the measurements were calculated and compared.

Chemicals. Isoproterenol, forskolin, 8-bromo-cyclic AMP (8Br-cAMP), bumetanide, DNDS, ellipticine, nystatin, ionomycin, and anthracene were obtained from Sigma-Aldrich. ChTx was purchased from Peptide Institute, Inc. (Osaka, Japan). Benzo[a]pyrene, fluoranthene, and H89 were products of Wako Pure Chemicals (Tokyo, Japan). The chemical structures of benzo[a]pyrene, anthracene, and fluoranthene are shown in Fig. 1. For permeabilization studies, nystatin was used as a 100 mM stock solution in DMSO and sonicated for 30 s just before use.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1. Chemical structure of benzo[a]pyrene, anthracene, and fluoranthene.

 

Data Analysis. Concentration-response curves in the present study were obtained using the computer program Cricket Graph version 1.5.3 for Macintosh (Computer Associates International Inc., Islandia, NY). All data are expressed as means ± S.E.M. with the number of experiments used (n). Statistical differences were determined by Student's t test or one-way analysis of variance, and p < 0.05 was considered to indicate statistical significance.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Effects of PAHs on Anion Secretion Stimulated by cAMP-Related Agents. Calu-3 cells respond to {beta}-adrenergic stimuli that contribute to anion secretion. Application of isoproterenol (10 nM) to the basolateral face led to a rapid increase in Isc, reaching a peak in 1 to 2 min and followed by a sustained Isc (Fig. 2A). The increased value from the basal Isc to the rapid peak (peak {Delta} Isc) and to the Isc measured at 30 min (sustained {Delta} Isc) after isoproterenol addition were 43.2 ± 4.2 µA/cm2 and 18.4 ± 3.2 µA/cm2 (n = 12), respectively. On the other hand, exposure of cells to fluoranthene (100 µM) from the apical surface, as a model of inhalation of a PAH, resulted in no significant changes in the Isc for at least a 30-min observation (Fig. 2A). Nevertheless, isoproterenol-induced responses were augmented by the apical pretreatment with fluoranthene so that peak {Delta} Isc and sustained {Delta} Isc were 90.6 ± 8.4 µA/cm2 and 60.4 ± 3.5 µA/cm2 (p < 0.0001, n = 9), respectively (Fig. 2A). The effect of fluoranthene is concentration-dependent (Fig. 2B). Fluoranthene at concentrations higher than 300 µM made experimental solutions very cloudy, so we performed dose-response experiments up to 300 µM. The presence of fluoranthene at 3 µM had no significant effect on the isoproterenol-induced Isc (sustained {Delta} Isc = 18.6 ± 2.3 µA/cm2, n = 5) compared with the control (18.4 ± 3.2 µA/cm2, n = 12; see Fig. 1A). Thus, considering the effects of fluoranthene at 300 µM as the maximum and the control as the minimum, the estimated EC50 is between 30 and 40 µM (see Fig. 2B). This effect of fluoranthene seems unlikely to be mediated by the PAH receptor because this potentiation was unaffected by ellipticine, a PAH receptor antagonist (Fig. 2C). This notion was also supported by the results that neither benzo[a]pyrene nor anthracene, PAH agonists, applied to the apical solution had any effect (Fig. 2C). Furthermore, no significant efficacy of basolaterally applied fluoranthene (100 µM), benzo[a]pyrene (100 µM), or anthracene (100 µM) was observed in the isoproterenol-induced responses (Fig. 2D).



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2. Effects of fluoranthene (FLT) and other PAHs on Isc in response to the {beta}-adrenergic agonist isoproterenol in Calu-3 cells. A, isoproterenol (ISO; 10 nM) applied to the basolateral solution 30 min after adding fluoranthene (100 µM) or its vehicle (0.1% DMSO). Note that the pretreatment with FLT markedly potentiated ISO-induced Isc, although the chemical itself caused no significant changes in the basal Isc. B, the concentration-dependent effects of FLT on {Delta} sustained Isc. C and D, effects of PAH agonists (benzo[a]pyrene, anthracene, and FLT) and a PAH antagonist (ellipticine) on the ISO-induced responses estimated by {Delta} sustained Isc. Benzopyrene (100 µM), anthracene (100 µM), and FLT (100 µM) were applied to apical (C) and basolateral (D) compartments 30 min prior to addition of ISO. Ellipticine (100 µM) was apically applied 10 min before addition of FLT (namely, 40 min prior to ISO addition). Data are means ± S.E.M. (n = 4–12). *, p < 0.0001.

 

The effects of fluoranthene were simulated in Isc responses to an adenylate cyclase activator, forskolin (10 µM; Fig. 3A), and to a cell-permeable cAMP analog, 8Br-cAMP (1 mM; Fig. 3B), suggesting that fluoranthene potentiates cAMP-mediated anion secretion. In addition, the fluoranthene-induced potentiation is highly sensitive to H89, a protein kinase A (PKA) inhibitor. Namely, the 8Br-cAMP-induced actions, estimated by sustained {Delta} Isc, were increased by the presence of fluoranthene from 11.3 ± 0.8 µA/cm2 to 60.0 ± 1.8 µA/cm2 (n = 4), but pretreatment with H89 (10 µM, 2 h) interrupted the augmentation by fluoranthene (sustained {Delta} Isc = 12.7 ± 1.0 µA/cm2, n = 4). These observations suggest that the effects of fluoranthene are subject to the activity of PKA.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3. Effects of FLT on the forskolin- and 8-bromo cAMP (8Br-cAMP)-induced Isc. After apical pretreatment with fluoranthene (100 µM) or its vehicle (0.1% DMSO), forskolin (10 µM; A) or 8Br-cAMP (1 mM; B) was applied to the basolateral solution. Data are means ± S.E.M. (n = 4–5).

 

Effects of Fluoranthene on Basolateral Anion Transporters. To help establish the ionic basis of fluoranthene effects, ion substitution experiments were performed (Fig. 4). To observe the Na+-K+-Cl cotransport function, was removed from the physiological solution. Under this condition, the initial and sustained components of the Isc response to isoproterenol were potentiated by the presence of fluoranthene (Fig. 4A). In the Cl free solution used to estimate the function, however, basal and isoproterenol-induced ISC were remarkably decreased, and exposure of the cells to isoproterenol caused only transient responses whose {Delta} Isc (the peak {Delta} Isc) was 13.1 ± 1.7 µA/cm2 (n = 5; Fig. 4B). The presence of fluoranthene augmented the peak {Delta} Isc (22.3 ± 7.5 µA/cm2, n = 5, p < 0.05), but this chemical had no significant effect on the Isc 4 to 30 min after addition of isoproterenol (Fig. 4B). Alternatively, to characterize the fluoranthene-potentiated anion secretion in the normal solution, DNDS- and bumetanide-sensitive Isc were evaluated in the presence and absence of fluoranthene (Fig. 5). Since sustained anion transport was produced by cAMP-related agents, including isoproterenol, this evaluation was performed 20 min after addition of isoproterenol and its vehicle (distilled water). The DNDS-sensitive component was increased by the application of isoproterenol (from 0.5 ± 0.1 µA/cm2, n = 4 to 11.1 ± 0.7 µA/cm2, n = 7; p < 0.0001), but it was abolished by the presence of fluoranthene (–0.1 ± 1.7 µA/cm2, n = 5, p < 0.0001; Fig. 5A). The bumetanide-sensitive component was also up-regulated by isoproterenol (from 0.7 ± 0.2 µA/cm2, n = 5 to 10.5 ± 0.7 µA/cm2, n = 11; p < 0.0001; Fig. 5B), but, in contrast, the presence of fluoranthene further augmented the component (57.8 ± 2.4 µA/cm2, n = 5, p < 0.0001; Fig. 5B). However, the effects of fluoranthene on the DNDS- and bumetanide-sensitive Isc were counteracted by ChTx (100 nM, basolateral) applied 10 min before additions of DNDS and bumetanide, respectively (Fig. 5, A and B).



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4. Effects of ISO on Isc in nominally Cl - and -free buffers in the presence and absence of FLT on the apical surface. Isc responses to ISO were potentiated by the presence of FLT in the -free buffers (A). In the Cl free solution, exposure of the cells to ISO caused only transient responses whose peak values are increased by the presence of FLT(B). However, FLT made no significant difference in the Isc 4 to 30 min after addition of ISO. FLT (100 µM) was applied to the apical compartment 30 min prior to addition of ISO. Data are means ± S.E.M. (n = 4–9).

 


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5. Alteration of bioelectric properties by the presence of FLT. A, DNDS (3 mM, basolateral)-sensitive Isc was measured 20 min after addition of isoproterenol [ISO (+)] and its vehicle [distilled water, ISO (–)]. Note that the ISO-induced increment in the DNDS-sensitive Isc in the absence of FLT [FLT (–)] was abolished by its presence [FLT (+)] applied 30 min before addition of ISO or its vehicle. However, pretreatment with ChTx (100 nM, basolateral) 10 min before addition of DNDS counteracted the suppression of DNDS-sensitive Isc [ChTx (+) +FLT (+)]. B, bumetanide (BMT; 50 µM, basolateral)-sensitive Isc was measured 20 min after addition of ISO and its vehicle. In contrast, the pretreatment with FLT potentiated the ISO-induced up-regulation of the BMT-sensitive Isc. However, pretreatment with ChTx 10 min before addition of BMT counteracted the potentiation of BMT-sensitive Isc [ChTx (+) + FLT (+)]. C, in correlation to the BMT-sensitive Isc, the ChTx (100 nM, basolateral)-sensitive Isc, which is less detected under basal and ISO-unstimulated conditions [ISO (–)], was also significantly increased under the FLT plus ISO condition. Data are means ± S.E.M. (n = 4–11) (D). Significant differences are expressed with *, p < 0.05, **, p < 0.01, and ***, p < 0.0001 (unpaired Student's t test).

 

Effect of Fluoranthene on the hIK-1 Channel and Cytosolic Ca2+ Concentrations. We measured the reduction of the sustained Isc generated by isoproterenol for 10 min after basolateral application of ChTx (100 nM), called the ChTx-sensitive Isc, and that was very small (1.1 ± 0.2 µA/cm2, n = 5; Fig. 5C). However, a larger ChTx-sensitive Isc was detected in the isoproterenol-stimulated monolayer when pretreated with fluoranthene for 30 min (47.3 ± 6.6 µA/cm2, n = 8; Fig. 5C), although fluoranthene itself had a modest effect on the ChTx-sensitive Isc (1.7 ± 0.4 µA/cm2, n = 4; Fig. 5C). On the basis of these observations, we speculated that the hIK-1 channel activities on the basolateral membrane were closely related to the fluoranthene-induced changes in the bioelectric properties described above. Thus, after permeabilization of the apical membrane with nystatin (50 µM), the basolateral membrane IK was followed under the establishment of transepithelial K+ gradients (Fig. 6). Fluoranthene gradually increased the IK, and consequently, the ChTx-sensitive IK in the absence of fluoranthene (0.4 ± 0.1 µA/cm2, n = 4) was raised to 8.5 ± 0.7 µA/cm2 (n = 4) 20 min after its addition (p < 0.0001; Fig. 6A). On the other hand, 8Br-cAMP (1 mM, basolateral) had a very small effect on the ChTx-sensitive IK (0.6 ± 0.1 µA/cm2, n = 6; Fig. 6B). Nevertheless, in the apical presence of fluoranthene, 8Br-cAMP remarkably augmented the ChTx-sensitive IK (31.6 ± 1.3 µA/cm2, n = 6, p < 0.0001; Fig. 6C). Since it is well known that hIK-1 channel activity correlates with [Ca2+]i, the effects of fluoranthene on the [Ca2+]i were examined. Figure 7A shows a representative recording of [Ca2+]i before and after addition of fluoranthene. A sustained oscillatory [Ca2+]i elevation was observed immediately after addition of fluoranthene, followed by the sustained component (217.9 ± 4.6 nM to 307.8 ± 9.7 nM, n = 9, p < 0.0001). The Ca2+ oscillation was still sustained around 30 min after addition of fluoranthene. Subsequently, application of 8Br-cAMP (1 mM, basolateral) 30 min after application of fluoranthene (Fig. 7B) resulted in no significant change in the [Ca2+]i, whose levels were 346.4 ± 12.7 nM versus 395.2 ± 41.7 nM.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6. Effects of FLT (100 µM, apical) and 8Br-cAMP (1 mM, basolateral) on the basolateral membrane IK following establishment of an apical-to-basolateral K+ gradient in the monolayer apically permeabilized with nystatin (50 µM). To estimate the involvement of the hIK-1 channel, the sensitivities of the IK to ChTx (100 nM, basolateral) was followed after exposure to FLT (A), 8Br-cAMP (B), or FLT + 8Br-cAMP (C). 8Br-cAMP (1 mM, basolateral) had a modest effect on the ChTx-sensitive IK in the absence of FLT [FLT (–); B]. Nevertheless, in the apical presence of fluoranthene [FLT (+)], 8Br-cAMP remarkably augmented the ChTx-sensitive IK. Data are means ± S.E.M. (n = 4–7).

 


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7. Representative recordings of [Ca2+]i responses to the presence of FLT. A [Ca2+]i elevation in a oscillatory fashion was observed immediately after addition of fluoranthene, followed by the sustained component (A). The Ca2+ oscillation was still sustained 30 min after addition of fluoranthene (B). In the presence of fluoranthene [FLT (+)], additional application of 8Br-cAMP (1 mM, basolateral) resulted in no significant change.

 


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Collection of airborne particulate samples in a city in Japan revealed that the average daily inhalations of three major PAHs were 17 ng/day/person for benzo[a]pyrene, 1 ng/day/person for anthracene, and 16 ng/day/person for fluoranthene (Matsumoto and Kashimoto, 1985Go). In the present study, we examined the effects of these three PAHs on the anion transport in human airway Calu-3 cells and demonstrated that only fluoranthene exposed to the apical membrane modulates the function. In polarized airway epithelia, and Cl secretion are primarily regulated by cytosolic cAMP and Ca2+, respectively (Smith and Welsh, 1992Go; Devor et al., 1999Go; Ito et al., 2001Go). Generally, the transepithelial anion transport is maintained through two steps: anion entry across the basolateral membrane and its export across the apical membrane (Ito et al., 2001Go). The apical CFTR is well known as a common pathway for and Cl export (Devor et al., 1999Go). Which anion will be transported across the airway is determined by the activity of basolateral anion transporters. Namely, secretion is maintained by the DNDS-sensitive cotransporter (NBC1), and Cl secretion is done by the bumetanide-sensitive Na+-K+-2Cl cotransporter (NKCC1)(Devor et al., 1999Go; Inglis et al., 2002Go). These two anion transporters have been characterized in many mammalian tissues, including Calu-3 cells (Romero and Boron, 1999Go; Inglis et al., 2002Go; Liedtke et al., 2002Go). Under cAMP-stimulated conditions, both NBC1 and NKCC1 seem likely to be activated by cAMP/PKA-dependent phosphorylation (Kurihara et al., 2002Go; Gross et al., 2003Go), as suggested in Fig. 5. In the fluoranthene-pretreated epithelia, however, isoproterenol failed to increase the DNDS-sensitive Isc, accompanied by larger potentiation of the bumetanide-sensitive Isc (Fig. 5, A and B), so that the total anion current, estimated by Isc, was consequently augmented (Fig. 2). Similar results were also obtained under the 8Br-cAMP-stimulated condition, suggesting that fluoranthene impaired cAMP-dependent up-regulation of uptake via NBC1, accompanied by augmentation of Cl uptake via NKCC1. In correlation to the up-regulated Cl secretion, the ChTx-sensitive component, which reflects the basolateral hIK-1 channel activity, was increased by the presence of fluoranthene (Fig. 5C). Furthermore, the effects of fluoranthene on the DNDS- and bumetanide-sensitive Isc were counteracted by the presence of ChTx (Fig. 5, A and B). Thus, these results suggest that the hIK-1 channel plays a key role in the modulatory effects of fluoranthene on the cAMP-stimulated anion secretion. Devor et al. (1999Go) reported that the switch between secretion and Cl secretion is determined by the basolateral membrane potential regulated by the hIK-1 channel. Namely, when the basolateral membrane is hyperpolarized by hIK-1 channel activation, the driving force for entry via NBC1 cotransporters, which electrogenically carry negative charges into the cell, is reduced, whereas that for Cl entry across the electroneutral NKCC1 is up-regulated. Since the hyperpolarization simultaneously provides a driving force for anion export across the apical CFTR, the activation of the hIK-1 channel would cause Cl dominant secretion.

In the free solution to estimate the NKCC1 function, the Isc response to isoproterenol was potentiated by the presence of fluoranthene, in agreement with the pharmacological data obtained using bumetanide (see Figs. 4A and 5B). In the Cl-free solution used to confirm the NBC1 function, however, basal and isoproterenol-induced Isc were remarkably decreased, and exposure of the cells to isoproterenol caused only transient responses. Furthermore, the peak in the presence of fluoranthene was rather higher that that in its absence, although there was no difference between the two groups of the Isc measured 4 to 30 min after addition of isoproterenol. Possibly, the absence of the major anion Cl produces a cytosolic charge that is negative relative to the outside, leading to a decrease in the sustained current generated by the NBC1. The fluoranthene-induced potentiation of the transient Isc under the Cl - free condition may be explained by the notion that export of remaining anions in the cytosol is up-regulated by the hIK-1-mediated driving force potentiated by fluoranthene.

The most important factor to activate the hIK-1 channel in Calu-3 cells is elevation of [Ca2+]i. Actually, fluoranthene caused a persistent increase in [Ca2+]i, resulting in up-regulation of the ChTx-sensitive IK (see Figs. 6A and 7A). However, the degrees of changes in [Ca2+]i (approximately 100 nM) and hIK-1-mediated K+ current had no significant effect on the Isc (see Figs. 2 and 3). This suggests that the hIK-dependent up-regulation of the NKCC1 by fluoranthene would be offset by the down-regulation of the NBC1. Furthermore, it is noteworthy that addition of 8Br-cAMP, which itself had a minor effect on the ChTx-sensitive IK (Fig. 6B), evoked a much larger augmentation in the ChTx-sensitive IK after pretreatment with fluoranthene without significant changes in [Ca2+]i (see Figs. 6C and 7B). Possibly, the PKA sensitization of the hIK-1 channel produced by fluoranthene is attributable to persistent increases in [Ca2+]i caused by the application of this chemical (see Fig. 7). The Ca2+-dependent sensitization of the hIK-1 channel to PKA was first reported by Gerlach et al. (2000Go). They showed that the hIK-1 channels, which were unresponsive to cAMP-elevating agents, were markedly activated by the cAMP-elevating agents after [Ca2+]i was elevated by ionomycin in Xenopus oocytes. Although it might be possible that fluoranthene directly modifies the sensitivity of the hIK-1 channel to PKA, mechanisms other than the synergism between Ca2+ and PKA have never been reported. Thus, the Ca2+-dependent mechanisms may be a more reasonable explanation of our results.

There is some evidence that PAHs such as anthracene, benzo[a]pyrene, and their metabolites possess the ability to cause sustained elevation of [Ca2+]i in HPB-ALL human T-lymphocytes (Krieger et al., 1994Go). However, [Ca2+]i in mammary epithelial cells was not elevated by anthracene (Tannheimer et al., 1997Go), and [Ca2+]i in human small airway epithelial cells was raised by a benzo[a]pyrene metabolite but not by benzo[a]pyrene itself (Jyonouchi et al., 2001Go). In Calu-3 cells also, neither benzo[a]pyrene nor anthracene caused sustained [Ca2+]i increases (unpublished data). Sustained [Ca2+]i elevation induced by PAHs may be due to inhibition of sacroplasmic/endoplasmic reticulum Ca2+ ATPase, as demonstrated by Krieger et al. (1995Go). These previous reports, however, provided no information regarding the reasons for the species difference in the effects and the relationship between Ca2+-mobilizing effects and the chemical structures of PAHs. Furthermore, there has been no report of the effects of fluoranthene and its metabolites on sacroplasmic/endoplasmic reticulum Ca2+ ATPase or [Ca2+]i. Thus, it is difficult to clearly define why fluoranthene is the only PAH examined that mobilizes [Ca2+]i and modulates anion secretion. Further investigations are necessary to clarify these points.

Yamaguchi et al. (1996Go) reported that fluoranthene induced apotosis in murine T cell hybridomas via Ca2+-dependent and PAH receptor-independent mechanisms. The present study demonstrated that representative PAH receptor agonists benzo[a]pyrene and anthracene had no effect on the Isc responses and that an PAH receptor antagonist, ellipticine, failed to counteract the effects of fluoranthene (Gasiewicz et al., 1996Go). Thus, the PAH receptor seems unlikely to be involved in Ca2+- and cAMP-mediated ion transport in this cell line.

As seen in Figs. 2 and 3, there is a difference in Isc characteristics for isoproterenol and the other cAMP-related agents, especially in the presence of fluoranthene. Namely, under isoproterenol-stimulated conditions, a component sustained at a lower level than the initial peak was generated, whereas immediate responses to forskolin and 8Br-cAMP were followed by a second rise (see Fig. 3). Since PKA appears to play a key role in the fluoranthene-induced modulation of Isc, the different Isc behaviors may indicate that the responses due to forskolin and 8Br-cAMP are more dependent on cAMP/PKA than those due to isoproterenol, especially in the second sustained phase. Indeed, it was reported that isoproterenol activates CFTR by the cooperative actions of two second messengers, heterometric G protein and cAMP/PKA, whereas forskolin and 8Br-cAMP do so only through cAMP/PKA-dependent mechasnisms (Reddy and Quinton, 2001Go).

transport is important to regulate the pH on the airway surface (Devor et al., 1999Go; Inglis et al., 2003Go). Analysis of exhaled breath condensate has suggested airway acidification in patients with cystic fibrosis, chronic obstructive lung disease, bronchiectasis, and acute asthma (Hunt et al., 2000Go; Kostikas et al., 2002Go; Tate et al., 2002Go). Lowering of the airway pH may be responsible for the development of airway inflammation (Kostikas et al., 2002Go). Thus, our results suggest that the effects of fluoranthene may affect pH homeostasis in the respiratory tract. Furthermore, cAMP-mediated Cl secretion potentiated by fluoranthene may produce large amounts of sputum, limiting airflow (Tamaoki et al., 1992Go).

In conclusion, the present study shows that a major environmental chemical, fluoranthene, which permeates the apical membrane, impaired cAMP-mediated secretion and potentiated Cl secretion, distinct from the other PAHs benzopyrene and anthracene. The modulation of anion transport appeared to be mediated by the hIK-1 channel, whose sensitivity to PKA may be up-regulated by the sustained [Ca2+]i elevation produced by fluoranthene. Thus, constant exposure to fluoranthene from the airway surface might be involved in airway surface acidification, resulting in exacerbation of various airway inflammatory diseases.


    Footnotes
 
This work was supported by Research Grant Funds from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Hibino Memorial Research Fund, and the Aichi Health Promotion Foundation (to Y.I.).

DOI: 10.1124/jpet.103.059089.

ABBREVIATIONS: PAH, polycyclic aromatic hydrocarbon; BMT, bumetanide; 8Br-cAMP, 8-bromo-cAMP; CFTR, cystic fibrosis transmembrane conductance regulator; ChTx, charybdotoxin; DEP, diesel exhaust particle; DNDS, 4,4'-dinitrostilbene-2,2'-disulfonic acid; FLT, fluoranthene; ISO, isoproterenol; NBC1, 4,4'-dinitrostilbene-2,2'-disulfonic acid-sensitive Na+-2HCO3 cotransporter; NKCC1, bumetanide-sensitive Na+-K+-2Cl cotransporter; PD, potential difference; PKA, protein kinase A; PSS, physiological saline solution; Isc, short-circuit current; DMSO, dimethyl sulfoxide; hIK-1 channel, human intermediate conductance Ca2+-activated K+ channel.

Address correspondence to: Dr. Yasushi Ito, Division of Respiratory Diseases, Department of Medicine, Nagoya Graduate School of Medicine, Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. E-mail: itoyasu{at}med.nagoyau.ac.jp


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Devor DC, Singh AK, Lambert LC, Deluca A, Frizzell RA, and Bridges RJ (1999) Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol 113: 743–760.[Abstract/Free Full Text]

Diaz-Sanchez D, Penichet-Garcia M, and Saxon A (2000) Diesel exhaust particles directly induce activated mast cells to degranulate and increase histamine levels and symptom severity. J Allergy Clin Immunol 106: 1140–1146.[CrossRef][Medline]

Fromme H, Oddoy A, Piloty M, Krause M, and Lahrz T (1998) Polycyclic aromatic hydrocarbons (PAH) and diesel engine emission (elemental carbon) inside a car and a subway train. Sci Total Environ 217: 165–173.[CrossRef][Medline]

Gasiewicz TA, Kende AS, Rucci G, Whitney B, and Willey JJ (1996) Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones and related compounds. Biochem Pharmacol 52: 1787–1803.[CrossRef][Medline]

Gerlach AC, Gangopadhyay NN, and Devor DC (2000) Kinase-dependent regulation of the intermediate conductance, calcium-dependent potassium channel, hIK1. J Biol Chem 275: 585–598.[Abstract/Free Full Text]

Goldman R, Enewold L, Pellizzari E, Beach JB, Bowman ED, Krishnan SS, and Shields PG (2001) Smoking increases carcinogenic polycyclic aromatic hydrocarbons in human lung tissue. Cancer Res 61: 6367–6371.[Abstract/Free Full Text]

Gross E, Fedotoff O, Pushkin A, Abuladze N, Newman D, and Kurtz I (2003) Phosphorylation-induced modulation of pNBC1 function: distinct roles for the amino- and carboxy-termini. J Physiol 549: 673–682.[Abstract/Free Full Text]

Haws C, Finkbeiner WE, Widdicombe JH, and Wine JJ (1994) CFTR in Calu-3 human airway cells: channel properties and role in cAMP-activated Cl conductance. Am J Physiol 266: L502–L512.

Hoffmann D and Hoffmann I (1997) The changing cigarette, 1950–1995. J Toxicol Environ Health 50: 307–364.[CrossRef][Medline]

Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TA, and Gaston B (2000) Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161: 694–699.[Abstract/Free Full Text]

Inglis SK, Finlay L, Ramminger SJ, Richard K, Ward MR, Wilson SM, and Olver RE (2002) Regulation of intracellular pH in Calu-3 human airway cells. J Physiol 538: 527–539.[Abstract/Free Full Text]

Inglis SK, Wilson SM, and Olver RE (2003) Secretion of acid and base equivalents by intact distal airways. Am J Physiol 284: L855–L862.

Ito Y, Sato S, Son M, Kondo M, Kume H, Takagi K, and Yamaki K (2002a) Bisphenol A inhibits Cl secretion by inhibition of basolateral K+ conductance in human airway epithelial cells. J Pharmacol Exp Ther 302: 80–87.[Abstract/Free Full Text]

Ito Y, Sato S, Son M, Kume H, Takagi K, and Yamaki K (2002b) Bioelectric toxicity caused by chlorpromazine in human lung epithelial cells. Toxicol Appl Pharmacol 183: 198–206.[Medline]

Ito Y, Son M, Kume H, and Yamaki K (2001) Novel effects of minocycline on Ca2+-dependent Cl secretion in human airway epithelial Calu-3 cells. Toxicol Appl Pharmacol 176: 101–109.[CrossRef][Medline]

Jayaraman S, Song Y, Vetrivel L, Shankar L, and Verkman AS (2001) Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration and pH. J Clin Investig 107: 317–324.[Medline]

Jyonouchi H, Sun S, Porter VA, and Cornfield DN (2001) Polycyclic aromatic hydrocarbon diol epoxides increase cytosolic Ca2+ of airway epithelial cells. Am J Respir Cell Mol Biol 25: 78–83.[Abstract/Free Full Text]

Kendall M, Duarte A, Rocha-Santos T, Hamilton R, and Williams I (2002) Airborne particulate-associated polyaromatic hydrocarbons, n-alkanes, elemental and organic carbon in three European cities. J Environ Monit 4: 890–896.[Medline]

Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, and Loukides S (2002) pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 165: 1364–1370.[Abstract/Free Full Text]

Krieger JA, Born JL, and Burchiel SW (1994) Persistence of calcium elevation in the HPB-ALL human T cell line correlates with immunosuppressive properties of polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol 127: 268–274.[CrossRef][Medline]

Krieger JA, Davila DR, Lytton J, Born JL, and Burchiel SW (1995) Inhibition of sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human T cells and other tissues. Toxicol Appl Pharmacol 133: 102–108.[CrossRef][Medline]

Kurihara K, Nakanishi N, Moore-Hoon ML, and Turner RJ (2002) Phosphorylation of the salivary Na+-K+-2Cl cotransporter. Am J Physiol 282: C817–C823.

Lee PS, Gorski RA, Hering WE, and Chan TL (1987) Lung clearance of inhaled particles after exposure to carbon black generated from a resuspension system. Environ Res 43: 364–373.[Medline]

Liedtke CM, Papay R, and Cole TS (2002) Modulation of Na-K-2Cl cotransport by intracellular Cl and protein kinase C-delta in Calu-3 cells. Am J Physiol 282: L1151–L1159.

Lodovici M, Akpan V, Giovannini L, Migliani F, and Dolara P (1998) Benzo[a]pyrene diol-epoxide DNA adducts and levels of polycyclic aromatic hydrocarbons in autoptic samples from human lungs. Chem Biol Interact 116: 199–212.[CrossRef][Medline]

Matsumoto H and Kashimoto T (1985) Average daily respiratory intake of polycyclic aromatic hydrocarbons in ambient air determined by capillary gas chromatography. Bull Environ Contam Toxicol 34: 17–23.[CrossRef][Medline]

Reddy MM and Quinton PM (2001) cAMP-independent phosphorylation activation of CFTR by G proteins in native human sweat duct. Am J Physiol 280: C604–C613.

Romero MF and Boron WF (1999) Electrogenic cotransporters: cloning and physiology. Annu Rev Physiol 61: 699–723.[CrossRef][Medline]

Sagai M, Furuyama A, and Ichinose T (1996) Biological effects of diesel exhaust particles (DEP). III. Pathogenesis of asthma like symptoms in mice. Free Radic Biol Med 21: 199–209.[CrossRef][Medline]

Shimura S (2000) Signal transduction of mucous secretion by bronchial gland cells. Cell Signal 12: 271–277.[CrossRef][Medline]

Smith JJ and Welsh MJ (1992) cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Investig 89: 1148–1153.

Sun JD, Wolff RK, Kanapilly GM, and McClellan RO (1984) Lung retention and metabolic fate of inhaled benzo(a)pyrene associated with diesel exhaust particles. Toxicol Appl Pharmacol 73: 48–59.[CrossRef][Medline]

Sydbom A, Blomberg A, Parnia S, Stenfors N, Sandstrom T, and Dahlen SE (2001) Health effects of diesel exhaust emissions. Eur Respir J 17: 733–746.[Abstract/Free Full Text]

Tamaoki J, Isono K, Sakai N, Kanemura T, and Konno K (1992) Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 5: 234–238.[Abstract]

Tannheimer SL, Barton SL, Ethier SP, and Burchiel SW (1997) Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis 18: 1177–1182.[Abstract/Free Full Text]

Tate S, MacGregor G, Davis M, Innes JA, and Greening AP (2002) Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 57: 926–929.[Abstract/Free Full Text]

Waldman JM, Lioy PJ, Greenberg A, and Butler JP (1991) Analysis of human exposure to benzo(a)pyrene via inhalation and food ingestion in the Total Human Environmental Exposure Study (THEES). J Expo Anal Environ Epidemiol 1: 193–225.[Medline]

Yamaguchi K, Near R, Shneider A, Cui H, Ju ST, and Sherr DH (1996) Fluoranthene-induced apoptosis in murine T cell hybridomas is independent of the aromatic hydrocarbon receptor. Toxicol Appl Pharmacol 139: 144–152.[CrossRef][Medline]


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
O. Kweon, S.-J. Kim, R. C. Jones, J. P. Freeman, M. D. Adjei, R. D. Edmondson, and C. E. Cerniglia
A Polyomic Approach To Elucidate the Fluoranthene-Degradative Pathway in Mycobacterium vanbaalenii PYR-1
J. Bacteriol., July 1, 2007; 189(13): 4635 - 4647.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Ohashi, Y. Ito, T. Matsuno, S. Sato, K. Shimokata, and H. Kume
Paradoxical Effects of Hydrogen Peroxide on Human Airway Anion Secretion
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 296 - 303.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. L. Hamilton and M. Kiessling
DCEBIO stimulates Cl- secretion in the mouse jejunum
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C152 - C164.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.059089v1
308/2/651    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, Y.
Right arrow Articles by Kume, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, Y.
Right arrow Articles by Kume, H.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition